224
Views
0
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Reasons and outcomes for patients receiving ICS/LABA agents prior to, and one month after, emergency department presentations for acute asthma

, MD, PhD, , MD, PhD, , MD, MPH, , MD, MSc, , MD, CCFP-EM, Dip PEC(SA), FCCHL, , MD, MSc, , MD, MHSc, , MD, MSc, , MD, MSc, , PhD, , MD, MSc & show all
Pages 985-994 | Received 05 Jun 2018, Accepted 29 Jul 2018, Published online: 12 Oct 2018

References

  • Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma—United States, 1980–1999. CDC Surveill Summ, MMWR 2002;51:1–13.
  • Manfreda J, Becklake MR, Sears MR, Chan-Yeung M, Dimich-Ward H, Siersted HC, Ernst P, Sweet L, Van Til L, Bowie DM, et al. Prevalence of asthma symptoms among adults aged 20–44 years in Canada. Can Med Assoc J 2001;164:995–1001.
  • Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59(5):469–478.
  • Kamble S, Bharmal M. Incremental direct expenditure of treating asthma in the United States. J Asthma 2009;46(1):73–80.
  • Theriault L, Hermus G, Goldfarb D, Stonebridge C, Bounajm F. Cost Risk Analysis for Chronic Lung Disease in Canada. The conference board of Canada report, 2012 Mar 15. http://www.conferenceboard.ca/e-library/abstract.aspx?did=4585 [last accessed 9 Mar 2016].
  • National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007;120:S94–S138.
  • The Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). www.ginasthma.org [last accessed 9 Mar 2016].
  • British Thoracic Society Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2014;69( Suppl 1):1–192.
  • Canadian Lung Association. Lung Facts, 1994 Update, 1993.
  • Worthington JR, Ahuja J. The value of pulmonary function tests in the management of acute asthma. Can Med Assoc J 1989;140:153–156.
  • Nowak RM, Pensler MI, Sarkar DD, Anderson JA, Kvale PA, Ortiz AE, Tomlanovich MC. Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma. Ann Emerg Med 1982;11:64–69.
  • Crane J, Pearce N, Burgess C, Woodman K, Robson B, Beasley R. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol 1992;21:737–744.
  • Lougheed MD, Lemiere C, Dell SD, Ducharme FM, FitzGerald JM, Leigh R, Licskai C, Rowe BH, et al. Canadian thoracic society asthma management continuum – 2009 consensus summary for children 6 years and over and adults. Can Respir J 2010;17:15–24.
  • Patel M, Shaw D. A review of standard pharmacological therapy for adult asthma - Steps 1 to 5. Chron Respir Dis 2015;12:165–176.
  • Rowe BH, Wong E, Blitz S, Diner B, Mackey D, Ross S, Senthilselvan A. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. Acad Emerg Med 2007;14:833–840.
  • Liao MM, Ginde AA, Clark S, Camargo CA, Jr. Salmeterol use and risk of hospitalization among emergency department patients with acute asthma. Ann Allergy Asthma Immunol 2010;104:478–484.
  • Rowe BH, Villa-Roel C, Majumdar SR, Abu-Laban RB, Aaron SD, Stiell IG, Johnson J, Senthilselvan A, AIR Investigators. Rates and correlates of relapse following ED discharge for acute asthma: a Canadian 20-site prospective cohort study. Chest 2015;147:140–149.
  • Beveridge R. CAEP issues. The Canadian Triage and Acuity Scale: a new and critical element in health care reform. Canadian Association of Emergency Physicians. J Emerg Med 1998;16:507–511.
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Resp Crit Care 1999;159:179–187.
  • Rowe BH, Voaklander DC, Wang D, Senthilselvan A, Klassen TP, Marrie TJ, Rosychuk RJ. Asthma presentations by adults to emergency departments in Alberta, Canada: a large population-based study. Chest 2009;135:57–65.
  • Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev 2010;(5):CD005535.
  • Cates CJ, Karner C. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database Syst Rev 2013;4:CD007313.
  • Bateman ED, Harrison TW, Quirce S, Reddel HK, Buhl R, Humbert M, Jenkins CR, Peterson S, Ostlund O, O'Byrne PM, Sears MR, Eriksson GS. Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res 2011;12:38.
  • Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405–1411.
  • Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE, Group GI. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004;170:836–844.
  • Stempel DA, Raphiou IH, Kral KM, Yeakey AM, Emmett AH, Prazma CM, Buaron KS, Pascoe SJ, AIR Investigators. Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone. N Engl J Med 2016;374:1822–1830.
  • Peters SP, Bleecker ER, Canonica GW, Park YB, Ramirez R, Hollis S, Fjallbrant H, Jorup C, Martin UJ. Serious asthma events with budesonide plus formoterol vs. budesonide alone. N Engl J Med 2016;375:850–860.
  • Cross E, Villa-Roel C, Majumdar SR, Bhutani M, Rosychuk RJ, Couperthwaite S, Rowe BH. Action plans in patients presenting to emergency departments with asthma exacerbations: frequency of use and description of contents. Can Respir J 2014;21:351–356.
  • Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, Bauman A, Hensley MJ, Walters EH. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003;(1):CD001117.
  • Villa-Roel C, Voaklander B, Ospina MB, Nikel T, Campbell S, Rowe BH. Effectiveness of written action plans for acute asthma: a systematic review. J Asthma 2018;55:188–195.
  • Villa-Roel C, Nikel T, Ospina M, Voaklander B, Campbell S, Rowe BH. Effectiveness of educational interventions to increase primary care follow-up for adults seen in the emergency department for acute asthma: a systematic review and meta-analysis. Acad Emerg Med 2016;23:5–13.
  • Johnston NW, Sears MR. Asthma exacerbations 1: epidemiology. Thorax 2006;61:722–728.
  • Lougheed MD, Garvey N, Chapman KR, Cicutto L, Dales R, Day AG, Hopman WM, Lam M, Sears MR, Szpiro K, et al. The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest 2006:129:909–917.
  • Stieb DM, Beveridge RC, Rowe BH, Walter SD, Judek S. Assessing diagnostic classification in an emergency department: implications for daily time series studies of air pollution. Am J Epidemiol 1998;148:666–670.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.